Maxalt-Mlt Related Clinical Trials
Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1) [Completed]
Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops [Withdrawn]
Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029) [Completed]
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030) [Completed]
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7) [Completed]
Two Rizatriptan Prescribing Portions for Treatment of Migraine [Completed]
Rizatriptan for Episodic Dizziness in Vestibular Migraine [Recruiting]
A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3) [Completed]
Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache [Completed]
Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms. [Completed]
A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis [Completed]
MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029) [Completed]
Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? [Completed]
Treatment of Multiple Attacks of Acute Migraine (0462-025) [Completed]
MK0462 in Treatment of Migraine With Recurrence (MK0462-022) [Completed]
The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache [Completed]
Rizatriptan 10 MG RPD in the Treatment of Acute Migraine [Completed]
Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081) [Completed]
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087) [Completed]
A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine [Completed]
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004) [Completed]
Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea [Completed]
Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy [Completed]
Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012) [Completed]
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066) [Completed]
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072) [Completed]
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065) [Completed]
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071) [Completed]
Drug and Non-Drug Treatment Of Severe Migraine [Completed]
Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine [Completed]
Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy [Completed]
A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data [Completed]
Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response? [Recruiting]
|
